Madrigal Pharmaceuticals
MDGL
MDGL
257 hedge funds and large institutions have $4.77B invested in Madrigal Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 87 increasing their positions, 83 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.89% less ownership
Funds ownership: 107.33% → 104.43% (-2.9%)
25% less capital invested
Capital invested by funds: $6.41B → $4.77B (-$1.63B)
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
Holders
257
Holding in Top 10
9
Calls
$208M
Puts
$165M
Top Buyers
| 1 | +$49.1M | |
| 2 | +$47M | |
| 3 | +$36.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$20.1M |
| 5 |
RI
RTW Investments
New York
|
+$19.9M |
Top Sellers
| 1 | -$74.1M | |
| 2 | -$41.8M | |
| 3 | -$32M | |
| 4 |
AC
Armistice Capital
New York
|
-$25.6M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$17.8M |